cancer. Malignant neoplasm without specification of site
Conditions
Interventions
Intervention 1: "In the intervention group": people will laugh yoga for 20-30 minutes before the first to fourth chemotherapy sessions. Laugh yogic exercises include four main clapping steps, deep bre
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: To chemotherapy, they have visited Imam Reza's center of Mashhad. Age between 18 and 60 years old. Be alert. Have non-metastatic cancer (based on diagnostic tests, signs and clinical examinations and an approved oncology doctor). Complete consent to participate in the research. Auditory problems (full hearing despite the use of auxiliary equipment) and visual (the ability to read a newspaper at a distance of 30 centimeters with glasses). The phone number should be available to the researcher for follow up. A chemotherapy regimen with moderate or severe nausea. The number of chemotherapy sessions between two to four sessions per week is prescribed to him. There are no symptoms of osteomyitis (such as redness, burning and mouth ulcers, the presence of false membranes, and sputum in the mouth). Do not have upper gastrointestinal cancer. Do not use radiotherapy at the same time. Mentally and physically, you can do yoga exercises.
Exclusion criteria
Exclusion criteria: Do not want to continue to participate in research. At the time of the research, there was a major stress (close relatives' death, financial failure, etc.). Worried and needs special care. The chemotherapy program is postponed by thrombocytopenia or any other factor. Diagnosis of metastasis is based on diagnostic tests by an oncology specialist. Symptoms of osteomyitis (such as redness, burning and mouth ulcers, false membranes, and sputum in the mouth). For whatever reason, you will not be able to attend laugh yoga sessions. Changes to the chemotherapy regimen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of nausea. Timepoint: Nausea before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Severe of nausea. Timepoint: Severe of Nausea before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Duration of nausea. Timepoint: Duration Nausea before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Frequency of vomiting. Timepoint: vomiting before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Duration of vomiting. Timepoint: Duration of vomiting before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Severe of nausea. Timepoint: severe of vomiting before the onset of the intervention and at each chemotherapy session for up to four sessions. Method of measurement: MORROW ASSESSMENT OF NAUSEA AND EMESIS.;Well-being score. Timepoint: En well-being is measured once before the start of the first chemotherapy session and once after the fourth session of chemotherapy. Method of measurement: En To measure the score of well-being, we will use the Warwick-Edinburgh Subjective Well-Being Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: sleep quality is measured once before the start of the first chemotherapy session and once after the fourth session of chemotherapy. Method of measurement: Petersburg Sleep Quality Tool.;Depression. Timepoint: Depression is measured once before the start of the first chemotherapy session and once after the fourth session of chemotherapy. Method of measurement: Beck Depression Tools.;Quality of Life. Timepoint: Quality of Life is measured once before the start of the first chemotherapy session and once after the fourth session of chemotherap. Method of measurement: European Organization for Research and Treatment of Cancer tools. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Namazi Nia
Mashhad University of Medical Sciences
Outcome results
None listed